Skip to main content

Angi Inc.

For the period ended Sep 30, 2025. Filed Nov 4, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 4, 2025

ANGI$6.69-3.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statement of Cash Flows

Nine Months Ended September 30,
20252024
(In thousands)
Cash flows from operating activities:
Net earnings$36,608$38,134
Adjustments to reconcile net earnings to net cash (used in) provided by operating activities:
Provision for credit losses37,27343,694
Depreciation32,14465,741
Deferred income taxes16,894(24,595)
Stock-based compensation expense8,74928,093
Non-cash lease expense (including impairment of right-of-use assets)5,49513,813
Other adjustments, net(1,255)373
Changes in assets and liabilities:
Accounts receivable(37,863)(44,665)
Other assets14,47221,094
Accounts payable and other liabilities(13,865)(3,945)
Operating lease liabilities(9,745)(13,870)
Income taxes payable and receivable(1,727)(8,307)
Deferred revenue(12,191)344
Net cash provided by operating activities74,989115,904
Cash flows from investing activities:
Capital expenditures(40,872)(37,547)
Proceeds from sales of fixed assets756
Net cash used in investing activities(40,797)(37,541)
Cash flows from financing activities:
Purchases of treasury stock(102,657)(25,675)
Purchase of noncontrolling interests—(16,019)
Withholding taxes paid on behalf of employees on net settled stock-based awards(6,907)(5,652)
Distribution from IAC pursuant to the tax sharing agreement—(198)
Net cash used in financing activities(109,564)(47,544)
Total cash (used) provided(75,372)30,819
Effect of exchange rate changes on cash and cash equivalents and restricted cash(484)448
Net (decrease) increase in cash and cash equivalents and restricted cash(75,856)31,267
Cash and cash equivalents and restricted cash at beginning of period416,545364,301
Cash and cash equivalents and restricted cash at end of period$340,689$395,568
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.